We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Philips Unveils Skylight Device Manager to Boost Ultrasound Efficiency
Read MoreHide Full Article
Key Takeaways
Philips launches Skylight Device Manager to centralize ultrasound fleet visibility and improve operations.
The cloud-based solution helps providers track equipment usage, plan services and optimize asset deployment.
Philips plans to expand Skylight to DXR systems, enhancing imaging fleet visibility and technology planning.
Koninklijke Philips (PHG - Free Report) recently introduced Philips Skylight Device Manager, a new cloud-based application designed to provide healthcare organizations with centralized visibility into their connected ultrasound systems. The solution combines system and transducer data to help healthcare providers assess equipment utilization, manage operations and improve service planning. The launch addresses the growing need for efficient medical equipment management amid financial pressures, staffing shortages and complex healthcare operations.
Per management, healthcare systems need to turn the growing volume of imaging data into actionable intelligence to make faster technology decisions. As imaging fleets expand and care demands evolve, Skylight is expected to help providers maximize their existing technology and better align future technology planning with the needs of care teams.
PHG Stock Trend Following the News
Following the announcement, PHG’s shares inched down 0.3% at yesterday’s close. Year to date, the stock has gained 10.1% against the industry’s 15.6% fall. Meanwhile, the S&P 500 has risen 6.1% during the same timeframe.
The introduction of Skylight Device Manager could strengthen Philips' position in the growing market for connected healthcare technologies. By extending its digital capabilities beyond imaging hardware, the company may create additional opportunities to deepen customer relationships and enhance the value of its installed ultrasound base. The solution could also support demand for Philips' broader digital health portfolio, potentially contributing to recurring software and service opportunities while strengthening its competitive edge in healthcare technology management.
PHG currently has a market capitalization of $29.38 billion.
Image Source: Zacks Investment Research
More on Philips Skylight Device Manager
Skylight Device Manager provides a centralized view of connected ultrasound systems, allowing operational, clinical and health technology management teams to identify underutilized equipment, compare usage across facilities and prioritize service requirements. The application can also support decisions related to staffing, scheduling, equipment deployment and capital investments.
The solution is available through Philips OneSpace Platform, a single sign-on digital environment that provides customers with centralized access to Philips' digital applications. Designed to support connected healthcare technologies, OneSpace is expected to expand with additional applications, educational resources and software across multiple imaging modalities.
Philips plans to extend Skylight Device Manager beyond ultrasound, with Diagnostic X-ray (DXR) systems among the first additional modalities expected to be supported. Connecting operational data across imaging systems could provide healthcare organizations with broader visibility into their equipment fleets, helping them optimize asset utilization and improve long-term technology planning.
The company will showcase Skylight Device Manager alongside its latest radiology innovations at RSNA 2026 in Chicago. The development complements Philips' broader strategy of integrating imaging systems, software, data, AI and services through connected digital platforms.
By expanding its cloud-based capabilities, Philips is positioning itself to address operational challenges across healthcare organizations while strengthening its portfolio of connected imaging solutions.
Industry Prospects Favoring the Market
According to Grand View Research, the global healthcare asset management market is estimated to reach $47.4 billion in 2026 and is projected to grow at a CAGR of 23.2% through 2033.
Factors such as rising healthcare expenditure, increasing adoption of digital healthcare technologies, growing need for efficient medical equipment utilization, staffing shortages, rising demand for real-time asset visibility and the need to streamline hospital operations and reduce equipment management inefficiencies are driving market growth.
Other News
Philips recently announced the U.S. commercial launch of its HyperVue Integrated System, a new single-room configuration designed to bring advanced coronary imaging and physiology assessment together in the catheterization laboratory (cath lab). The system combines DeepOCT+NIRS intravascular imaging with X1-FFR physiology assessment to support more efficient workflows and informed clinical decisions during percutaneous coronary intervention (PCI) procedures.
Philips recently launched UniGuide 3D Live Guidance in Europe and other CE-marked markets, extending its Azurion image-guided therapy platform. The solution integrates pre-procedural CT insights into live workflows, supporting more informed, patient-specific decisions during coronary, structural heart and complex vascular procedures. It offers 3D overlay visualization and synchronized imaging to improve procedural guidance and workflow efficiency. The solution is not yet available in the United States.
Some better-ranked stocks from the broader medical space are Glaukos (GKOS - Free Report) , Intuitive Surgical (ISRG - Free Report) and West Pharmaceutical Services (WST - Free Report) .
Glaukos, currently flaunting a Zacks Rank #1 (Strong Buy), reported third-quarter 2026 adjusted earnings per share (EPS) of 47 cents, which surpassed the Zacks Consensus Estimate by 491.7%. Revenues of $211 million beat the Zacks Consensus Estimate by 25%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GKOS has an estimated earnings growth rate of 155.6% for 2026. The company’s earnings beat estimates in three of the trailing four quarters and missed once, the average surprise being 138.6%.
Intuitive Surgical, currently carrying a Zacks Rank #2 (Buy), reported third-quarter 2026 adjusted EPS of $3.00, which beat the Zacks Consensus Estimate by 13.6%. Revenues of $3.05 billion surpassed the Zacks Consensus Estimate by 4.9%.
Intuitive Surgical has a long-term estimated growth rate of 15.5%. ISRG’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 15.1%.
West Pharmaceutical, currently carrying a Zacks Rank #2, reported a third-quarter 2026 adjusted EPS of $2.66, which surpassed the Zacks Consensus Estimate by 22%. Revenues of $874.5 million beat the Zacks Consensus Estimate by 5.9%.
WST has an estimated long-term earnings growth rate of 17.4%. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 18.6%.
Image: Bigstock
Philips Unveils Skylight Device Manager to Boost Ultrasound Efficiency
Key Takeaways
Koninklijke Philips (PHG - Free Report) recently introduced Philips Skylight Device Manager, a new cloud-based application designed to provide healthcare organizations with centralized visibility into their connected ultrasound systems. The solution combines system and transducer data to help healthcare providers assess equipment utilization, manage operations and improve service planning. The launch addresses the growing need for efficient medical equipment management amid financial pressures, staffing shortages and complex healthcare operations.
Per management, healthcare systems need to turn the growing volume of imaging data into actionable intelligence to make faster technology decisions. As imaging fleets expand and care demands evolve, Skylight is expected to help providers maximize their existing technology and better align future technology planning with the needs of care teams.
PHG Stock Trend Following the News
Following the announcement, PHG’s shares inched down 0.3% at yesterday’s close. Year to date, the stock has gained 10.1% against the industry’s 15.6% fall. Meanwhile, the S&P 500 has risen 6.1% during the same timeframe.
The introduction of Skylight Device Manager could strengthen Philips' position in the growing market for connected healthcare technologies. By extending its digital capabilities beyond imaging hardware, the company may create additional opportunities to deepen customer relationships and enhance the value of its installed ultrasound base. The solution could also support demand for Philips' broader digital health portfolio, potentially contributing to recurring software and service opportunities while strengthening its competitive edge in healthcare technology management.
PHG currently has a market capitalization of $29.38 billion.
Image Source: Zacks Investment Research
More on Philips Skylight Device Manager
Skylight Device Manager provides a centralized view of connected ultrasound systems, allowing operational, clinical and health technology management teams to identify underutilized equipment, compare usage across facilities and prioritize service requirements. The application can also support decisions related to staffing, scheduling, equipment deployment and capital investments.
The solution is available through Philips OneSpace Platform, a single sign-on digital environment that provides customers with centralized access to Philips' digital applications. Designed to support connected healthcare technologies, OneSpace is expected to expand with additional applications, educational resources and software across multiple imaging modalities.
Philips plans to extend Skylight Device Manager beyond ultrasound, with Diagnostic X-ray (DXR) systems among the first additional modalities expected to be supported. Connecting operational data across imaging systems could provide healthcare organizations with broader visibility into their equipment fleets, helping them optimize asset utilization and improve long-term technology planning.
The company will showcase Skylight Device Manager alongside its latest radiology innovations at RSNA 2026 in Chicago. The development complements Philips' broader strategy of integrating imaging systems, software, data, AI and services through connected digital platforms.
By expanding its cloud-based capabilities, Philips is positioning itself to address operational challenges across healthcare organizations while strengthening its portfolio of connected imaging solutions.
Industry Prospects Favoring the Market
According to Grand View Research, the global healthcare asset management market is estimated to reach $47.4 billion in 2026 and is projected to grow at a CAGR of 23.2% through 2033.
Factors such as rising healthcare expenditure, increasing adoption of digital healthcare technologies, growing need for efficient medical equipment utilization, staffing shortages, rising demand for real-time asset visibility and the need to streamline hospital operations and reduce equipment management inefficiencies are driving market growth.
Other News
Philips recently announced the U.S. commercial launch of its HyperVue Integrated System, a new single-room configuration designed to bring advanced coronary imaging and physiology assessment together in the catheterization laboratory (cath lab). The system combines DeepOCT+NIRS intravascular imaging with X1-FFR physiology assessment to support more efficient workflows and informed clinical decisions during percutaneous coronary intervention (PCI) procedures.
Philips recently launched UniGuide 3D Live Guidance in Europe and other CE-marked markets, extending its Azurion image-guided therapy platform. The solution integrates pre-procedural CT insights into live workflows, supporting more informed, patient-specific decisions during coronary, structural heart and complex vascular procedures. It offers 3D overlay visualization and synchronized imaging to improve procedural guidance and workflow efficiency. The solution is not yet available in the United States.
Koninklijke Philips N.V. Price
Koninklijke Philips N.V. price | Koninklijke Philips N.V. Quote
PHG’s Zacks Rank & Key Picks
Currently, PHG carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader medical space are Glaukos (GKOS - Free Report) , Intuitive Surgical (ISRG - Free Report) and West Pharmaceutical Services (WST - Free Report) .
Glaukos, currently flaunting a Zacks Rank #1 (Strong Buy), reported third-quarter 2026 adjusted earnings per share (EPS) of 47 cents, which surpassed the Zacks Consensus Estimate by 491.7%. Revenues of $211 million beat the Zacks Consensus Estimate by 25%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GKOS has an estimated earnings growth rate of 155.6% for 2026. The company’s earnings beat estimates in three of the trailing four quarters and missed once, the average surprise being 138.6%.
Intuitive Surgical, currently carrying a Zacks Rank #2 (Buy), reported third-quarter 2026 adjusted EPS of $3.00, which beat the Zacks Consensus Estimate by 13.6%. Revenues of $3.05 billion surpassed the Zacks Consensus Estimate by 4.9%.
Intuitive Surgical has a long-term estimated growth rate of 15.5%. ISRG’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 15.1%.
West Pharmaceutical, currently carrying a Zacks Rank #2, reported a third-quarter 2026 adjusted EPS of $2.66, which surpassed the Zacks Consensus Estimate by 22%. Revenues of $874.5 million beat the Zacks Consensus Estimate by 5.9%.
WST has an estimated long-term earnings growth rate of 17.4%. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 18.6%.